Sign in
Enrolling by invitationNo phase

Surgery with double tissue closure for jaw bone damage from medicines

Tests a jaw surgery for bone damage caused by medicines.

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure
Status
Enrolling by invitation
People taking part
20 people, planned
Started
3 Jan 2025
Expected to end
26 Dec 2026
Type of study
Interventional
Treatments tested
  • management of medication related osteonecrosis of the jaw
Record updated
19 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with medication related osteonecrosis of the jaw (MRONJ), meaning jaw bone damage caused by medicines. They will have surgery to remove the damaged bone, then the wound is closed with a double tissue flap.

Sex
All sexes can join.
Disease stage
MRONJ that needs more than conservative (non-surgical) treatment.
Earlier treatment
People who have had radiotherapy in the past cannot join.

Main reasons for not taking part

  • Past radiotherapy
  • Only conservative (non-surgical) treatment is needed

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • patients with MRONJ

Who cannot take part

  • Patients had a history of radiotherapy
  • Patients need only conservative treatment

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

20 patients with MRONJ underwent surgical debridement using piezosurgery then closure using double periosteal flap

The group in the trial

  • management of medication related osteonecrosis of the jawTreatment being tested

    The buccal mucoperiosteal flap was elevated to expose the area of osteonecrosis in the mandible. it was debrided using piezosurgery then closure was achieved using double periosteal flap

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Management of Medication Related Osteonecrosis of the Jaws Using Piezosurgery With Simultaneous Double Periosteal Flap Closure
Plain-language title
Surgery with double tissue closure for jaw bone damage from medicinesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
19 May 2026